Use of medetomidine-fentanyl-fluanisone combinations in the badger.
Wolfensohn
S E
SE
University of Oxford, University Laboratory of Physiology.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D000835:Animals, Wild / Q000502:physiology; D002090:Butyrophenones / Q000037:antagonists & inhibitors; D002335:Carnivora / Q000502:physiology*; D005260:Female; D005283:Fentanyl / Q000037:antagonists & inhibitors; D006993:Hypnotics and Sedatives / Q000037:antagonists & inhibitors; D007093:Imidazoles / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008297:Male; D020926:Medetomidine; D009270:Naloxone / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D002090:Butyrophenones; D006993:Hypnotics and Sedatives; D007093:Imidazoles; C050701:atipamezole; C005014:fluanisone; D009270:Naloxone; D020926:Medetomidine; D005283:Fentanyl